Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121370353 | 12137035 | 3 | F | 2013 | 20160914 | 20160302 | 20160921 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-014026 | BRISTOL MYERS SQUIBB | 53.00 | YR | F | Y | 0.00000 | 20160921 | MD | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121370353 | 12137035 | 1 | PS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | N | 125118 | |||||||||
| 121370353 | 12137035 | 2 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | N | 125118 | |||||||||
| 121370353 | 12137035 | 3 | SS | ENBREL | ETANERCEPT | 1 | Unknown | N | 0 | ||||||||||
| 121370353 | 12137035 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 20 MG, UNK | N | 0 | 20 | MG | |||||||
| 121370353 | 12137035 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 15 MG, UNK | N | 0 | 15 | MG | |||||||
| 121370353 | 12137035 | 6 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | N | 0 | ||||||||||
| 121370353 | 12137035 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | N | 0 | ||||||||||
| 121370353 | 12137035 | 8 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | N | 0 | ||||||||||
| 121370353 | 12137035 | 9 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 10 MG, QD | N | 0 | 10 | MG | TABLET | QD | |||||
| 121370353 | 12137035 | 10 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 121370353 | 12137035 | 11 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | U | 0 | 5 | MG | BID | ||||||
| 121370353 | 12137035 | 12 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 121370353 | 12137035 | 13 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 400 MG, QD | U | 0 | 400 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121370353 | 12137035 | 1 | Rheumatoid arthritis |
| 121370353 | 12137035 | 3 | Rheumatoid arthritis |
| 121370353 | 12137035 | 4 | Rheumatoid arthritis |
| 121370353 | 12137035 | 6 | Rheumatoid arthritis |
| 121370353 | 12137035 | 7 | Rheumatoid arthritis |
| 121370353 | 12137035 | 8 | Rheumatoid arthritis |
| 121370353 | 12137035 | 9 | Rheumatoid arthritis |
| 121370353 | 12137035 | 10 | Polyarthritis |
| 121370353 | 12137035 | 11 | Rheumatoid arthritis |
| 121370353 | 12137035 | 12 | Product used for unknown indication |
| 121370353 | 12137035 | 13 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121370353 | 12137035 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121370353 | 12137035 | Alopecia | |
| 121370353 | 12137035 | Carpal tunnel syndrome | |
| 121370353 | 12137035 | Drug ineffective | |
| 121370353 | 12137035 | Hip fracture | |
| 121370353 | 12137035 | Intervertebral disc disorder | |
| 121370353 | 12137035 | Nausea | |
| 121370353 | 12137035 | Rheumatoid arthritis | |
| 121370353 | 12137035 | Stress fracture | |
| 121370353 | 12137035 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121370353 | 12137035 | 1 | 20150122 | 0 | ||
| 121370353 | 12137035 | 2 | 20160129 | 0 | ||
| 121370353 | 12137035 | 9 | 201306 | 201309 | 0 |